These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19996280)

  • 1. Antimitotic effect of the retinoid 4-oxo-fenretinide through inhibition of tubulin polymerization: a novel mechanism of retinoid growth-inhibitory activity.
    Appierto V; Tiberio P; Cavadini E; Casalini P; Cappelletti G; Formelli F
    Mol Cancer Ther; 2009 Dec; 8(12):3360-8. PubMed ID: 19996280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
    Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-oxo-N-(4-hydroxyphenyl)retinamide: two independent ways to kill cancer cells.
    Tiberio P; Cavadini E; Abolafio G; Formelli F; Appierto V
    PLoS One; 2010 Oct; 5(10):e13362. PubMed ID: 20976277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1.
    Villani MG; Appierto V; Cavadini E; Valsecchi M; Sonnino S; Curley RW; Formelli F
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6265-75. PubMed ID: 15448016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.
    Appierto V; Villani MG; Cavadini E; Gariboldi M; De Cecco L; Pierotti MA; Lambert JR; Reid J; Tiberio P; Colombo N; Formelli F
    Oncogene; 2007 Jun; 26(27):3952-62. PubMed ID: 17213814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium 4-Carboxymethoxyimino-(4-HPR) a Novel Water-Soluble Derivative of 4-Oxo-4-HPR Endowed with
    Tiberio P; Cavadini E; Cleris L; Dallavalle S; Musso L; Daidone MG; Appierto V
    Front Pharmacol; 2017; 8():226. PubMed ID: 28491037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines.
    Kazmi SM; Plante RK; Visconti V; Lau CY
    Cancer Res; 1996 Mar; 56(5):1056-62. PubMed ID: 8640761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Methoxyestradiol suppresses microtubule dynamics and arrests mitosis without depolymerizing microtubules.
    Kamath K; Okouneva T; Larson G; Panda D; Wilson L; Jordan MA
    Mol Cancer Ther; 2006 Sep; 5(9):2225-33. PubMed ID: 16985056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide.
    Panigone S; Debernardi S; Taya Y; Fontanella E; Airoldi R; Delia D
    Oncogene; 2000 Aug; 19(35):4035-41. PubMed ID: 10962560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth.
    Jordan MA; Kamath K; Manna T; Okouneva T; Miller HP; Davis C; Littlefield BA; Wilson L
    Mol Cancer Ther; 2005 Jul; 4(7):1086-95. PubMed ID: 16020666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective Inhibition of Spindle Microtubules by a Tubulin-Binding Quinazoline Derivative.
    Sawada JI; Ishii H; Matsuno K; Sato M; Suzuki Y; Asai A
    Mol Pharmacol; 2019 Nov; 96(5):609-618. PubMed ID: 31471455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1.
    Poliakov E; Samuel W; Duncan T; Gutierrez DB; Mata NL; Redmond TM
    PLoS One; 2017; 12(4):e0176487. PubMed ID: 28448568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells.
    Appierto V; Villani MG; Cavadini E; Lotan R; Vinson C; Formelli F
    Cell Death Differ; 2004 Mar; 11(3):270-9. PubMed ID: 14647238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the effect of ATRA, 4-HPR, and CD437 in bladder cancer cells.
    Zou C; Zhou J; Qian L; Feugang JM; Liu J; Wang X; Wu S; Ding H; Zou C; Liebert M; Grossman HB
    Front Biosci; 2006 Sep; 11():2007-16. PubMed ID: 16720286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Water-soluble derivatives of 4-oxo-N-(4-hydroxyphenyl) retinamide: synthesis and biological activity.
    Musso L; Tiberio P; Appierto V; Cincinelli R; Cavadini E; Cleris L; Daidone MG; Dallavalle S
    Chem Biol Drug Des; 2016 Oct; 88(4):608-14. PubMed ID: 27135197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
    Ling YH; Jiang JD; Holland JF; Perez-Soler R
    Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MT7, a novel compound from a combinatorial library, arrests mitosis via inhibiting the polymerization of microtubules.
    Zhang Z; Meng T; He J; Li M; Tong LJ; Xiong B; Lin L; Shen J; Miao ZH; Ding J
    Invest New Drugs; 2010 Dec; 28(6):715-28. PubMed ID: 19705064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear retinoid receptors are involved in N-(4-hydroxyphenyl) retinamide (Fenretinide)-induced gene expression and growth inhibition in HL-60 acute myeloid leukemia cells.
    Ozpolat B; Tari AM; Mehta K; Lopez-Berestein G
    Leuk Lymphoma; 2004 May; 45(5):979-85. PubMed ID: 15291358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect and mechanism of millepachine-disrupted spindle assembly in tumor cells.
    Wu W; Liu F; Su A; Gong Y; Zhao W; Liu Y; Ye H; Zhu J
    Anticancer Drugs; 2018 Jun; 29(5):449-456. PubMed ID: 29649038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma.
    Sheikh MS; Shao ZM; Li XS; Ordonez JV; Conley BA; Wu S; Dawson MI; Han QX; Chao WR; Quick T
    Carcinogenesis; 1995 Oct; 16(10):2477-86. PubMed ID: 7586155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.